Katja Fink

2 ta ish

Vir Biotechnology (Switzerland)

1. Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

   Luca Piccoli, Young‐Jun Park, M. Alejandra Tortorici +47

   Maqola20203 iqtibos

   ABIABI:AkademIndex/2026.other.371368

2. A perspective on potential antibody-dependent enhancement of SARS-CoV-2

   Ann M. Arvin, Katja Fink, Michael Schmid +6

   Maqola20203 iqtibos

   ABIABI:AkademIndex/2026.other.571383